StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen marketed Product Support (Phase 4, Label Expansion & Manufacturing R&D) ($M) ($M)

Form 10-K Item 7 MD&A R&D Expense by Category Table

Latest, FY2025
1,259
Period ended Dec 31, 2025
Change on a year earlier
-21.3%
1,600 in FY2024
History
13 years
Since FY2013
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMarketed Product Support (Phase 4, Label Expansion & Manufacturing R&D) ($M) ($M)Year on yearSource
FY2025Dec 31, 20251,259-21.3%Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗
FY2024Dec 31, 20241,600+22.9%Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗
FY2023Dec 31, 20231,302+8.9%Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗
FY2022Dec 31, 20221,196-16.0%Form 10-K (amgn-20241231.htm, filed 2025-02-14) ↗
FY2021Dec 31, 20211,423-1.0%Form 10-K (amgn-20231231.htm, filed 2024-02-14) ↗
FY2020Dec 31, 20201,437+2.3%Form 10-K (amgn-20221231.htm, filed 2023-02-09) ↗
FY2019Dec 31, 20191,405-6.5%Form 10-K (amgn-20211231.htm, filed 2022-02-16) ↗
FY2018Dec 31, 20181,502-12.2%Form 10-K (amgn-20201231.htm, filed 2021-02-09) ↗
FY2017Dec 31, 20171,711-2.1%Form 10-K (amgn-12312019x10kq42019.htm, filed 2020-02-12) ↗
FY2016Dec 31, 20161,747+45.9%Form 10-K (amgn-12312018x10kq42018.htm, filed 2019-02-13) ↗
FY2015Dec 31, 20151,197+50.0%Form 10-K (amgn-12312017x10k.htm, filed 2018-02-13) ↗
FY2014Dec 31, 2014798-11.3%Form 10-K (amgn-12312016x10k.htm, filed 2017-02-14) ↗
FY2013Dec 31, 2013900–Form 10-K (amgn-12312015x10k.htm, filed 2016-02-16) ↗

Cite this data

StockData. (2026). Amgen Marketed Product Support (Phase 4, Label Expansion & Manufacturing R&D) ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/rd_cat_marketed

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.